BMP8A Antikörper (C-Term)
-
- Target Alle BMP8A Antikörper anzeigen
- BMP8A (Bone Morphogenetic Protein 8A (BMP8A))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BMP8A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF), Immunocytochemistry (ICC)
- Kreuzreaktivität
- Human, Maus
- Aufreinigung
- Purified by antigen-affinity chromatography.
- Immunogen
- Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of human BMP8A. The exact sequence is proprietary.
- Isotyp
- IgG
- Top Product
- Discover our top product BMP8A Primärantikörper
-
anti-Bone Morphogenetic Protein 8A (BMP8A) (Internal Region) antibody
BMP8A Reaktivität: Human, Ratte, Maus WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Bone Morphogenetic Protein 8A (BMP8A) (C-Term) antibodyBMP8A Reaktivität: Human WB, ELISA, IF, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Bone Morphogenetic Protein 8A (BMP8A) (C-Term) antibodyBMP8A Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Bone Morphogenetic Protein 8A (BMP8A) (AA 271-298), (C-Term) antibodyBMP8A Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB32225 unconjugated
anti-Bone Morphogenetic Protein 8A (BMP8A) (AA 261-399) antibodyBMP8A Reaktivität: Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Bone Morphogenetic Protein 8A (BMP8A) (C-Term) antibodyBMP8A Reaktivität: Human WB, IF, IC Wirt: Kaninchen Polyclonal unconjugated
anti-Bone Morphogenetic Protein 8A (BMP8A) (AA 253-302) antibodyBMP8A Reaktivität: Human WB, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Bone Morphogenetic Protein 8A (BMP8A) (AA 271-298) antibodyBMP8A Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
- Kommentare
-
Positive Control: H1299 , Raji
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.38 mg/mL
- Buffer
- 0.1M Tris-Glycine ( pH 7), 10 % Glycerol, 0.01 % Thimerosal
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
- Target
- BMP8A (Bone Morphogenetic Protein 8A (BMP8A))
- Andere Bezeichnung
- bone morphogenetic protein 8a (BMP8A Produkte)
- Synonyme
- Bmp7r1 antikoerper, OP-2 antikoerper, OP2 antikoerper, bmp8 antikoerper, bone morphogenetic protein 8a antikoerper, Bmp8a antikoerper, BMP8A antikoerper, bmp8a antikoerper
- Hintergrund
- Bone morphogenetic protein 8a,Induces cartilage and bone formation. May be the osteoinductive factor responsible for the phenomenon of epithelial osteogenesis. Plays a role in calcium regulation and bone homeostasis.
- Molekulargewicht
- 45 kDa
- Gen-ID
- 353500
- UniProt
- Q7Z5Y6
- Pathways
- Negative Regulation of Hormone Secretion
-
